997 LENOX DRIVE, LAWRENCEVILLE, NJ
Reports First Quarter 2026 Financial Results and Provides Business Update
Change of Control Agreements for Executives at Imunon, Inc.
Annual Report to Security Holders
Financial Results, Press Release
Imunon, Inc. Registers Additional $7 Million of Common Stock Shares
Chief Scientific Officer Retirement - Khursheed Anwer Steps Down
Interim CFO Resignation - Kimberly Graper Steps Down at Imunon, Inc.
Announces Pricing of $7.0 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules
Q1
FY 2025
Q3
Q2
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Notice of Exempt Offering of Securities
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence